The largest database of trusted experimental protocols

Sta r evolution instrument

Manufactured by Diagnostica Stago
Sourced in France

The STA‐R Evolution® instrument is a laboratory coagulation analyzer used for the quantitative determination of various hemostasis parameters. It automates the processes of sample handling, reagent addition, and measurement of coagulation times. The instrument performs hemostasis testing on a wide range of samples, including plasma, whole blood, and other body fluids.

Automatically generated - may contain errors

2 protocols using sta r evolution instrument

1

Routine Coagulation Analyses in Citrated Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Routine coagulation analyses were performed in citrated plasma using a STA‐R Evolution® instrument and reagents from Diagnostica Stago (Asniéres, France). STA® SPA+ reagent was used for prothrombin time‐international normalized ratio (PT‐INR), and STA®‐PPT for activated partial thromboplastin time (APTT; Diagnostica Stago) and clot detection methods. The colorimetric kits STACHROM® protein C and STACHROM® ATIII (Diagnostica Stago) were used for analysis of protein C and anti‐thrombin III, respectively. The clot‐based test kit STACLOT® protein S (Diagnostica Stago) and the COATEST® APCTM Resistance V kit from Chromogenix (Bedford, MA, USA) were used for analysis of protein S and activated protein C (APC) resistance, respectively. FVIII, von Willebrand factor antigen and activity, lupus anti‐coagulant, anti‐cardiolipin IgG and IgM and anti‐beta2‐glycoprotein I IgG and IgM were estimated in blood samples from the C5D individual by routine analyses at the Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
+ Open protocol
+ Expand
2

Fibrinogen Levels and Postpartum Hemorrhage

Check if the same lab product or an alternative is used in the 5 most similar protocols
After women arrived at the labour ward, blood was collected in tubes containing 0.13 M citrate either from direct venipuncture or from intravenous cannulae. The blood samples were centrifuged at 2000 g at room temperature for 20 min. Plasma was frozen at -70°C until analysed. Fibrinogen concentration in plasma was analysed in batches with the Clauss method (STA ® Fibrinogen 5, Diagnostica Stago, Asnières sur Seine, France) on a STA-R Evolution instrument (Diagnostica Stago). The non-pregnant reference range is 2.0-4.5 g litre -1 . Estimated blood loss (EBL) at delivery and postpartum were determined by the responsible midwife by weighing surgical sponges and pads and by measuring collected blood.
Patient characteristics (age, body mass index, parity, gestational week at delivery, epidural analgesia, diagnosis and bleeding at delivery) were obtained from electronic patient records (Obstetrix, Siemens AB, Healthcare Sector, Upplands Väsby, Sweden). Severe postpartum haemorrhage was defined as EBL >1000 ml. 4 11 Predefined subgroups included women with different age, body mass index, parity, gestational weeks, fibrinogen concentrations, preeclampsia, induction of labour, use of oxytocin stimulation, epidural analgesia, Caesarean section and women undergoing uterus exploration (Table 2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!